Bruce Car - Sep 28, 2022 Form 3 Insider Report for Biohaven Ltd. (BHVN)

Role
Chief Scientific Officer
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
Sep 28, 2022
Transactions value $
$0
Form type
3
Date filed
10/5/2022, 04:55 PM
Previous filing
Mar 3, 2022
Next filing
Oct 5, 2022

No securities are beneficially owned.

Remarks:

On September 28, 2022, the Reporting Person was appointed as the Chief Scientific officer of the Issuer.